PMO Interview with the Innovator Series: Volume 2
Peter Hirth, PhD
Video Categories: PMO Interview with the Innovator Series
The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.
As we learn more about a person’s genetic makeup, the more we are able to target medicines to his/her needs and benefit. With continued research, Dr. Stainthorpe explains, we will be able to identify markers that allow us to target medicines more precisely to get better performance and reduce waste.
The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Dr Lawrence Weiss, Medical Director at Clarient Diagnostic Services, discussing personalized medicine in diagnostics and with MultiOmyx™.